KPIs & Operating Metrics(New)
Adult Nutritionals Revenue By RegionAdult Nutritionals Revenue By Region AnnualAssets By SegmentBreakdown Of AssetsCapital ExpenditureCore Laboratory Revenue By RegionCore Laboratory Revenue By Region AnnualCovid Test Diagnostic Revenue By RegionCovid Test Diagnostic Revenue By Region AnnualCovid Test Revenue By CategoryCovid Test Revenue By Category AnnualDiabetes Care Revenue By RegionDiabetes Care Revenue By Region AnnualDiagnostics Revenue By TestsDiagnostics Revenue By Tests AnnualDiagonostics Revenue By CategoryDiagonostics Revenue By Category AnnualElectrophysiology Revenue By RegionElectrophysiology Revenue By Region AnnualEmployee StstisticsEstablished Pharmaceutical Revenue By CategoryEstablished Pharmaceutical Revenue By Category AnnualGross MarginGross Margin%Heart Failure Revenue By RegionHeart Failure Revenue By Region AnnualIncome Before Income Tax By RegionInternational Revenue By Geographic AreaManufacturing Facilities Count By SegmentMedical Devices Revenue By CategoryMedical Devices Revenue By Category AnnualMolecular Revenue By RegionMolecular Revenue By Region AnnualNeuromodulation Revenue By RegionNeuromodulation Revenue By Region AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Nutritionals Revenue By CategoryNutritionals Revenue By Category AnnualOperating Earnings By SegmentOperating Earnings By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationPediatric Nutritionals Revenue By RegionPediatric Nutritionals Revenue By Region AnnualPoint Of Care Revenue By RegionPoint Of Care Revenue By Region AnnualProperty, Plant And Equipment, Net BreakdownRapid Diagnostics Revenue By RegionRapid Diagnostics Revenue By Region AnnualRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Rhythm Management Revenue By RegionRhythm Management Revenue By Region AnnualStructural Heart Revenue By RegionStructural Heart Revenue By Region AnnualVascular Revenue By RegionVascular Revenue By Region Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Gross Margin (2017 - 2025)

Abbott Laboratories (ABT) has disclosed Gross Margin for 17 consecutive years, with 57.05% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 208.0% to 57.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 56.42% through Dec 2025, up 101.0% year-over-year, with the annual reading at 56.42% for FY2025, 101.0% up from the prior year.
  • Gross Margin hit 57.05% in Q4 2025 for Abbott Laboratories, up from 55.36% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 59.53% in Q3 2021 to a low of 51.61% in Q2 2021.
  • Historically, Gross Margin has averaged 55.99% across 5 years, with a median of 55.6% in 2024.
  • Biggest YoY gain for Gross Margin was 457bps in 2022; the steepest drop was -399bps in 2022.
  • Year by year, Gross Margin stood at 58.44% in 2021, then fell by -7bps to 54.48% in 2022, then grew by 2bps to 55.51% in 2023, then dropped by -1bps to 54.97% in 2024, then grew by 4bps to 57.05% in 2025.
  • Business Quant data shows Gross Margin for ABT at 57.05% in Q4 2025, 55.36% in Q3 2025, and 56.44% in Q2 2025.